[Federal Register Volume 66, Number 174 (Friday, September 7, 2001)]
[Notices]
[Page 46801]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-22502]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Draft Guideline for Prevention of Intravascular Catheter-Related 
Infections

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (DHHS).

ACTION: Notice of availability and request for public comment.

-----------------------------------------------------------------------

SUMMARY: This notice is a request for review of and comment on the 
Draft Guideline for Prevention of Intravascular Catheter-Related 
Infections, available on the CDC website at www.cdc.gov/ncidod/hip/ivguide.htm. The guideline has been developed for practitioners who 
insert and maintain intravascular catheters and for personnel who are 
responsible for monitoring and preventing infections in healthcare 
settings. The guideline is intended to replace the Guideline for 
Prevention of Intravascular Device-Related Infections published in 
1996.

DATES: Comments on the Draft Guideline for Prevention of Intravascular 
Catheter-Related Infections must be received in writing on or before 
October 22, 2001.

FOR FURTHER INFORMATION CONTACT: Requests for copies of the Draft 
Guideline for Prevention of Intravascular Catheter-Related Infections 
should be submitted to the Resource Center, Attention: IVGuide, 
Division of Healthcare Quality Promotion, CDC, Mailstop E-68, 1600 
Clifton Rd., NE, Atlanta, Georgia 30333; fax 404 498-1244; e-mail: 
[email protected]; or Internet: www.cdc.gov/ncidod/hip/ivguide.htm.

ADDRESSES: Comments on the Draft Guideline for Prevention of 
Intravascular Catheter-Related Infections should be submitted to the 
Resource Center, Attention: IVGuide, Division of Healthcare Quality 
Promotion, CDC, Mailstop E-68, 1600 Clifton Road, NE, Atlanta, Georgia 
30333; fax 404-498-1244; e-mail: [email protected]; or Internet: 
www.cdc.gov/ncidod/hip/ivguide.htm.

SUPPLEMENTARY INFORMATION: The Draft Guideline for Prevention of 
Intravascular Catheter-Related Infections is designed to provide 
healthcare practitioners with background information and specific 
recommendations to reduce the incidence of intravascular catheter-
related bloodstream infections: Part I: Intravascular Catheter-Related 
Infections: An Overview reviews pivotal issues and controversies in 
intravascular catheter use and maintenance. These issues include 
definitions and diagnosis of catheter-related infection, barrier 
precautions during catheter insertion, skin antisepsis, intervals for 
replacement of catheters and intravenous fluids and administration 
sets, catheter site case, the role of specialized intravascular 
catheter personnel and the use of antimicrobial/antiseptic impregnated 
catheters, prophylactic systemic antibiotics, flush solutions, and 
anticoagulants. Part II: Recommendations for Prevention of 
Intravascular Catheter-Related Infections provides consensus 
recommendations of the Healthcare Infection Control Practices Advisory 
Committee (HICPAC) and other professional societies. Most 
recommendations are pertinent for the inpatient, outpatient, and home 
care setting, unless otherwise noted.
    HICPAC was established in 1991 to provide advice and guidance to 
the Secretary and the Assistant Secretary for Health, DHHS; the 
Director, CDC; and the Director, National Center for Infectious 
Diseases, regarding the practice of infection control and strategies 
for surveillance, prevention, and control of healthcare-associated 
infections in U.S. healthcare facilities. The committee advises CDC on 
guidelines and other policy statements regarding prevention of 
healthcare-associated infections and related adverse events.

    Dated: August 31, 2001.
James D. Seligman,
Associate Director for Program Services, Centers for Disease Control 
and Prevention.
[FR Doc. 01-22502 Filed 9-6-01; 8:45 am]
BILLING CODE 4163-18-M